Nektar Therapeutics
NKTR
#5780
Rank
S$1.43 B
Marketcap
S$70.64
Share price
7.00%
Change (1 day)
245.85%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$5.56

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$5.46. In 2024 the company made an earnings per share (EPS) of S-$4.52 an increase over its 2023 EPS that were of S-$28.28.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$5.5623.01%
2024S-$4.52-84.02%
2023S-$28.28-25.89%
2022S-$38.16-31.12%
2021S-$55.4014.86%
2020S-$48.23-1.19%
2019S-$48.81-163.96%
2018S$76.32-725.4%
2017S-$12.20-42.73%
2016S-$21.3183.33%
2015S-$11.6239.53%
2014S-$8.33-69.29%
2013S-$27.12-6.67%
2012S-$29.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
S$16.83-408.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.22-140.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.81-279.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
S$0.01291-100.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$3.92-171.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
S-$0.85-84.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$2.67-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
S$13.48-346.79%๐Ÿ‡บ๐Ÿ‡ธ USA